Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer
Conditions: Pancreatic Adenocarcinoma Metastatic Interventions: Drug: Penpulimab; Drug: Anlotinib; Drug: Nab paclitaxel; Drug: Gemcitabine Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Hospitals | Pancreas | Pancreatic Cancer | Research